Form 10-K, Biotechnology, FACTOR, Medicine, Risk, Form 10-Q
Ginkgo Bioworks Appoints Dr. Behzad Mahdavi as Senior Vice President of Biopharma Manufacturing & Life Science Tools
BOSTON, Sept. 1, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced that Behzad Mahdavi, Ph.D., MBA, has joined as senior vice president of biopharma manufacturing and life sciences tools. In this new role, Dr. Mahdavi ...
Ginkgo Bioworks Appoints Dr. Behzad Mahdavi as Senior Vice President of Biopharma Manufacturing & Life Science Tools
BOSTON, Sept. 1, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced that Behzad Mahdavi, Ph.D., MBA, has joined as ...
We are sorry, we could not find the related article
If you are curious about Biotech and Career and Jobs
Please click on:
Subscribe to Biotech - Career and Jobs
Ginkgo Bioworks Appoints Dr. Behzad Mahdavi as Senior Vice President of Biopharma Manufacturing & Life Science Tools
Ginkgo Bioworks Appoints Dr. Behzad Mahdavi as Senior Vice President of Biopharma Manufacturing & Life Science Tools - read this article along with other careers information, tips and ...
Ginkgo Bioworks Acquires Bitome, an Integrated Metabolite Monitoring Platform
Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced that it has acquired certain assets from Bitome, a company pioneering real-time metabolite ...
mRNA Victoria and Ginkgo Bioworks Announce Partnership to Grow the Bioeconomy & International Biosecurity Capabilities
MELBOURNE, Australia and BOSTON, Nov. 17, 2021 /PRNewswire/ — mRNA Victoria, the agency of the Australian State of Victoria Government charged with building the State’s mRNA manufacturing ...
Ginkgo Bioworks and the Rwanda Development Board Announce Plans to Develop and Implement New Biosecurity Capabilities in Rwanda
Collaboration aims to leverage innovative biosecurity capabilities to promote global health security and accelerate the development of the regional bioeconomy BOSTON and KIGALI, Rwanda, ...
Persephone Biosciences and Ginkgo Bioworks Announce Collaboration to Develop Novel Therapeutics
/PRNewswire/ -- Persephone Biosciences Inc., a synthetic biology company reimagining patient and infant health, and Ginkgo Bioworks (NYSE: DNA), the leading...
Twist Bioscience and Ginkgo Bioworks Sign New Collaboration
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its sili
Selecta Biosciences and Ginkgo Bioworks Announce New Collaboration to Develop Next-Generation Gene Therapy Capsids
The Investor Relations website contains information about Selecta Biosciences Inc 's business for stockholders, potential investors, and financial analysts.
Cronos Group Inc. (CRON) and Ginkgo Bioworks Announce Achievement of THCV Equity Milestone
Cronos Group and Ginkgo Bioworks Announce Achievement of THCV Equity Milestone Cronos…
XpresSpa Group and Ginkgo Bioworks Collaboration with the Centers for Disease Control and Prevention (CDC) COVID-19 Biosurveillance Program Expands to Include Detection of the New Omicron Variant
The current COVID-19 variant surveillance program is offered at John F. Kennedy International Airport, Newark-Liberty International Airport, San Francisco International Airport, and is now ...